164 related articles for article (PubMed ID: 25870693)
1. Involvement of vasoactive substances in hemodynamics disturbances in cirrhosis.
Grancea-Iancu M
J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):40-3. PubMed ID: 25870693
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
3. A multilevel modeling framework to study hepatic perfusion characteristics in case of liver cirrhosis.
Peeters G; Debbaut C; Cornillie P; De Schryver T; Monbaliu D; Laleman W; Segers P
J Biomech Eng; 2015 May; 137(5):051007. PubMed ID: 25473885
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
6. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
7. Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells.
Shu Y; Liu X; Huang H; Wen Q; Shu J
Mol Biol Rep; 2021 Feb; 48(2):1915-1924. PubMed ID: 33609264
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological characteristics of cutaneous microcirculation in patients with liver cirrhosis: relationships to cardiovascular hemodynamics and plasma neurohormonal factors.
Seino Y; Ohki K; Nakamura T; Tsukamoto H; Takano T; Aramaki T; Okumura H; Hayakawa H
Microvasc Res; 1993 Sep; 46(2):206-15. PubMed ID: 8246819
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats.
Turkseven S; Bolognesi M; Brocca A; Pesce P; Angeli P; Di Pascoli M
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G298-G304. PubMed ID: 31813234
[TBL] [Abstract][Full Text] [Related]
12. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
13. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of redox pathways in liver fibrosis.
Torok NJ
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G667-G674. PubMed ID: 27562057
[TBL] [Abstract][Full Text] [Related]
15. Relationship between oxidative stress levels and activation state on a hepatic stellate cell line.
Guimarães EL; Franceschi MF; Grivicich I; Dal-Pizzol F; Moreira JC; Guaragna RM; Borojevic R; Margis R; Guma FC
Liver Int; 2006 May; 26(4):477-85. PubMed ID: 16629652
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats.
Tang S; Huang Z; Jiang J; Gao J; Zhao C; Tai Y; Ma X; Zhang L; Ye Y; Gan C; Su W; Jia X; Liu R; Wu H; Tang C
Life Sci; 2021 May; 272():119203. PubMed ID: 33577848
[TBL] [Abstract][Full Text] [Related]
17. Role of oxidative stress and molecular changes in liver fibrosis: a review.
Sánchez-Valle V; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
Curr Med Chem; 2012; 19(28):4850-60. PubMed ID: 22709007
[TBL] [Abstract][Full Text] [Related]
18. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4.
Du JJ; Sun JC; Li N; Li XQ; Sun WY; Wei W
Acta Pharmacol Sin; 2021 Jul; 42(7):1090-1100. PubMed ID: 33116250
[TBL] [Abstract][Full Text] [Related]
20. Role of vasoactive substances and cellular effectors in the pathophysiology of cirrhotic portal hypertension: the past, the present and the future--Georges Brohée Lecture.
Laleman W
Acta Gastroenterol Belg; 2009; 72(1):9-16. PubMed ID: 19402365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
